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1. Introduction 
Gas chromatography and thin-layer chromatography 
are the two main techniques that are now used for 
the detection of amphetamines in blood and urine [ 1, 
21. Since these two methods require solvent extrac- 
tion and evaporation, they are relatively time-con- 
suming and have a lack of sensitivity. For clinical and 
forensic purposes, a more rapid, specific, sensitive, 
and reliable technique for the determination of am- 
phetamines in biological fluids is obviously needed. 
We now report the development of a radioimmuno- 
assay for measuring nanogram levels of amphetamines 
in urine. 
2. Materials and methods 
IV-(4-aminobutyl)methamphetamine was prepared 
by refluxing methamphetamine, containing a small 
amount of radioactive tracer, with one equivalent of 
N-(4-bromobutyl) phthalimide in dry absolute etha- 
nol for 12 hr (fig. 1). One equivalent of 85% hydrazine 
hydrate aqueous solution was then added to the mix- 
ture and heated for another 2 hr. The reaction mix- 
ture was acidified, then filtrated and the filtrate ex- 
tracted three times with chloroform. After readjust- 
ing the pH to 10 with sodium hydroxide, the free 
amine was separated from the aqueous layer. 
The N-(4-aminobutyl) methamphetamine was 
coupled to bovine serum albumin (BSA) by a carbodi- 
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in-ride method (fig. 1). To the mixture of 1.36 g BSA 
and 1.34 g N-(4-aminobutyl)methamphetamine in 
50 ml water at pH 6, we added 7.66 g of 1 ethyl-3- 
(3-dimethylaminopropyl) carbodiimide (EDC) in 
12 ml of water. The mixture was stirred for 3 hr at 
room temp. The reaction mixture was then dialyzed 
against distilled water for 4 days. Based upon the 
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Fig. 1. Preparation of N-(4-aminobutyl) methamphetamine 
and conjugation to BSA. Structure (1) is methamphetamine; 
structure (2) is N-(4-aminobutyl)methamphetamine; struc- 
ture (3) is N(4aminobutyl) methamphetamine- BSA con- 
jugate. EDC: 1-Ethyl-3-3(3-dimethylaminopropyl>carbodi- 
imide. 
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amount of the radioactive tracer bound to the pro- 
tein carrier, the degree of conjugation was calculated 
to be 93 mol of methamphetamine/mol of BSA car- 
rier (mol.wt. = 68 000). 
Rabbits were inoculated subcutaneously with 
1 mg of N-(4-aminobutyl) methamphetamine-BSA 
conjugate emulsified with 50% Freund’s complete 
adjuvant in saline for 8-10 weeks. The hapten-binding 
capacity of the antiserum was determined by a satu- 
rated ammonium sulfate method. Serial dilutions of 
antiserums were incubated with 0.25 pmole (approx. 
2200 cpm) of [ 3H] amphetamine (New England Nu- 
clear, 6.24 Ci/mmole as the sulfate) at 4°C overnight. 
An equal volume of a saturated ammonium sulfate 
solution was added to all tubes after incubation. After 
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centrifugation, the supernatant containing free am- 
phetamine was dissolved in 10 ml of scintillation 
fluid and the radioactivity was counted in a Nuclear 
Chicago spectrometer. The standard curves were 
fitted to the equation: 
(C, + c,*)b = - (l/K).(b/f) + c, (1) 
a modification of Scatchard equation [3], to obtain 
the affinity constant K and the concentration of anti- 
body binding sites C, . In eq. 1 C,, * and Cn are respec- 
tively the concentrations of labeled and unlabeled 
amphetamine; while b and fstand for the fractions 
of bound and free amphetamine, respectively. We ob- 
tained K = 2 X 107 to 2 X lo9 M-l and C, = 2 X 10-s 
to 6 X lo-* M for our methamphetamine antiserums 
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Fig. 2. Displacement of binding of [ 3H] amphetamine by nonradioactive amphetamine. The affinity constant and the concentra- 
tion of binding sites were calculated from the black dotted (0) points to be 2.4 X 10’ M-’ and 6.2 X lo-* M, respectively. Using 
these two constants and the eq. 1 the line was generated. The different mark points were run at different times. The vertical bar 
indicates the standard deviation (? S.D.) of six to eight runs. In each assay, 0.050 ml urine was incubated with 0.200 ml of anti- 
serum and fixed amounts of [3H] amphetamine in 0.01 M phosphate-buffered solution. 
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at 1:250 dilution. Good fitting of the standard curves 
to the equation [I] indicates that the binding of am- 
phetmaine to the antibody obeys the law of mass ac- 
tion and that all antibody-binding sites in the anti- 
serum may be considered as equivalent. 
For assays of amphetamine in urine, 0.050 ml of 
urine, containing various amounts of unlabeled am- 
phetamine, was incubated with 0.200 ml of anti- 
serum and a fixed amount (2200 cpm of [SHJam- 
phetamine (labeled in 0.01 M phosphate-buffered 
solution (pH 7.6). After separation of the free- and 
bound-labeled amphetamine by the saturated am- 
monium sulfate method, the radioactivity of free 
labeled amphetamine was counted. 
3. Results and discussion 
The principle of the radioimmunoassay is based 
upon the displacement of bound labeled amphet- 
amine in the antiserum by unlabeled amphetamine. 
A tube that contained labeled amphetamine and anti- 
serum, but no unlabeled amphetamine, measured 
minimum radioactivity. The addition of samples with 
increasing amounts of unlabeled amphetamine to 
fixed amounts of labeled amphetamine and antiserum 
resulted in increasing displacement of [3H] amphet- 
amine from binding to the antibody. Thus we ob- 
served an increase in the percentage free [3H] amphet- 
amine and the radioactivity (figs. 2 and 3). The basic 
principle is similar to that of the radioimmunoassays 
for morphine [4] and barbiturates [5] . We found 
that the length of incubation could be reduced from 
overnight to 30 min without sacrificing the sensitivity 
as shown in fig. 3. Although in the latter case the 
amount of displacement was lower and the control 
of timing was essential for good reproducibility, it 
substantially saved the overall turn-around time for 
the assay. In all cases, the method detected amphet- 
amine in urine at 30 ng/rnl with better than 99% con- 
fidence. This corresponds to 1.5 ng of amphetamine 
in 50 1.11 of urine, the actual amounts used in the tests. 
The antibody bound equally well to amphetamine 
and methamphetamine, the two main central nerve 
stimulants. This was predicted since these two drugs 
are different only in a methyl substituent on the 
amino group to which the bridge chain was linked. 
Additional substituent on the o-carbon and the fl- 
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Fig. 3. Displacement of binding [3H] amphetamine by non- 
radioactive amphetamine with two incubation times: A) Incu- 
bated for 30 min at room temp; B) Incubated overnight at 
4°C. The vertical bar on each point represents the three 
standard deviations (+ 3 SD.) of eight runs. 
carbon, however, reduced the cross reactivity* to 
0.25 and 0.15, respectively, as observed for mephenter- 
ine and norephedrine. The cross reactivities for o- 
methylbenzylamine, tyramine, and isoproterenol 
were further down to 0.0006,0.0008 and 0, respec- 
tively. The data indicate that the phenyl group is the 
major moiety which determines the antibody specifi- 
city. We also compared these results with those of 
antiserums produced from the conjugate prepared 
by direct coupling of amphetamine with BSA with- 
out extending the bridge chain (fig. 1). The extra 
bridge chain actually enhanced both the affinity and 
specificity of the antibody. This similar effect seems 
to explain the high affinity and specificity of the 
phenobarbiturate-antibody reported earlier [5]. 
* Cross reactivity: l/(the amounts of substance which dis- 
placed [ 3H] amphetamine quivalent o that displaced 
by 1 ng of unlabeled amphetamine) using 1:250 dilution 
of antiserum. 
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